N
SRTA

Nuveen’s Strata Critical Medical Inc SRTA Stock Holding History

Nuveen’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$614K Buy
146,954
+962
+0.7% +$4.63K ﹤0.01% 2765
2025
Q4 		$702K Hold
145,992
– – ﹤0.01% 2754
2025
Q3 		$739K Hold
145,992
– – ﹤0.01% 2759
2025
Q2 		$588K Sell
145,992
-207,704
-59% -$676K ﹤0.01% 2825
2025
Q1 		$1.27M Sell
353,696
-727,484
-67% -$2.61M ﹤0.01% 2525
2024
Q4 		$4.6M Buy
1,081,180
+342,250
+46% +$1.3M ﹤0.01% 2026
2024
Q3 		$2.17M Buy
738,930
+485,430
+191% +$1.55M ﹤0.01% 2377
2024
Q2 		$882K Buy
253,500
+12,990
+5% +$43.3K ﹤0.01% 2777
2024
Q1 		$685K Buy
240,510
+74,800
+45% +$231K ﹤0.01% 2854
2023
Q4 		$585K Buy
165,710
+7,402
+5% +$21.2K ﹤0.01% 2952
2023
Q3 		$410K Sell
158,308
-1,529
-1% -$5.37K ﹤0.01% 2904
2023
Q2 		$630K Sell
159,837
-8,519
-5% -$27K ﹤0.01% 2854
2023
Q1 		$569K Sell
168,356
-17,116
-9% -$69.8K ﹤0.01% 2775
2022
Q4 		$664K Sell
185,472
-21,601
-10% -$92.3K ﹤0.01% 2814
2022
Q3 		$834K Sell
207,073
-5,314
-3% -$27.3K ﹤0.01% 2824
2022
Q2 		$947K Buy
+212,387
New +$1.53M ﹤0.01% 2803

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen's SRTA Position: Q1 2026 in Review

Nuveen increased its Strata Critical Medical Inc (SRTA) stake by 0.66% in Q1 2026, buying an estimated $4.63K and bringing the position to 146,954 shares worth $614K. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

Nuveen first reported a position in SRTA in Q2 2022 and has held it in 16 quarters since. The position peaked at $4.6M in Q4 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Nuveen held 146,954 shares of Strata Critical Medical Inc worth $614K as of Q1 2026.
  • Nuveen bought 962 Strata Critical Medical Inc shares in Q1 2026, an estimated $4.63K.
  • Strata Critical Medical Inc made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2765 holding.
  • Nuveen first reported a position in Strata Critical Medical Inc in Q2 2022 and has held it in 16 quarters since.
  • Nuveen's Strata Critical Medical Inc position peaked at $4.6M in Q4 2024.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.